TriSalus outlines $54M-$57M 2026 revenue forecast while TriNav Advance clearance runs ~5 months past goal
TriSalus Life Sciences, Inc. Common Stock · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · Now $3.67
+22% in 7d after detection
Post-detection moves
1h
—
1d
-5.6%
3d
+13%
7d
+22%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS